₹20/- For Intraday, F&O, Currencies & Commodities
Sahajanand Medical Technologies Limited IPO
Sahajanand Med Tech has registered for an initial public offering (IPO) in the amount of Rs.1,500 crore with SEBI. A fresh issuance of Rs.410.33 crore and an offer for the sale of equity shares worth Rs.1,089.67 crore are included in the IPO. Dhiraj Kumar S Vasoya is selling Rs.100 crore worth of shares, Shree Hari Trust is selling Rs.33.75 crore worth of shares, and Samara Capital Markets Holding is selling Rs.635.56 crore worth of shares, and NHPEA Sparkle Holding BV is selling Rs.320.36 crore worth of shares.
They are also mulling an Rs.185 crore pre-IPO placement. Axis Capital Ltd, BofA Securities India Ltd, Edelweiss Financial Services, and UBS Securities India Pvt Ltd are the book-running lead managers for this issuance.
Opening Date
To be announced
Closing Date
To be announced
Price Band
To be announced
Issue Size
To be announced
Face Value
To be announced
Market Lot
To be announced
Opening Date
To be announced
Closing Date
To be announced
Price Band
To be announced
Issue Size
To be announced
Face Value
To be announced
Market Lot
To be announced
Listing at NSE, BSE
Sahajanand Medical Technologies Ltd. IPO Important Dates
| IPO Open Date | To be announced |
|---|---|
| IPO Close Date | To be announced |
| Allotment Date | To be announced |
| Initiation Of Refunds | To be announced |
| Credit Of Shares To Demat Account |
To be announced |
| IPO Listing Date | To be announced |
| UPI Mandate Expiry Date | To be announced |
About Sahajanand Medical Technologies Limited
Sahajanand Medical Tech was founded in 2001 and is a major medical device firm that specialises in the research, development, production, and marketing of vascular devices all over the world. In India, they maintained a 31 per cent market share in the drug-eluting stent market in FY21. As of March 31, 2021, Sahajanand was among the top five corporations in market share in nations such as Germany, the Netherlands, Poland, and Italy. They sell and distribute their products in 69 countries throughout the world. Interventional cardiology, structural heart treatment, and peripheral intervention are all areas where their products are employed. Surat, Galway, Ireland, and Nonthaburi, Thailand are the locations of their three research and development centres. Sahajanand Medical Technologies has received 67 patents worldwide, with 17 more patents in the works and four design registrations in India.
The firm has 946 full-time workers, 410 contract employees, and 24 consultants as of March 31, 2021. Their sales force consists of 131 salespeople scattered over 37 locations. Sterling AddLife India Pvt Ltd, Fortis Hospitals, Max Hospitals, and Paras Hospitals are among Sahajanand Med Tech's most important clients.
Sahajanand Medical Technologies Limited IPO Objectives
Here are a few quick reasons why Sahajanand Medical Technologies Limited going public:
- Repayment/ prepayment of certain indebtedness availed by the Company and our Subsidiaries.
- Funding the working capital requirements of its indirect foreign subsidiary, Vascular Innovations Co. Ltd. (“Vascular Innovations”).
- General corporate purposes.
Why should you invest in the Sahajanand Medical Technologies Limited IPO?
- They are a leading medical devices company that researches, designs, develops, manufactures and markets vascular devices globally.
- As of March 31, 2021, they have been granted 67 patents globally with a pipeline of additional 17 patents and four design registrations in India.
Financial Highlights
| Particulars | FY21 | FY20 | FY19 |
|---|---|---|---|
| Revenue | 588.52 | 479.9 | 326.11 |
| PAT | (72.38) | 25.43 | 25.43 |
| EPS | (8.13) | 2.69 | 3.67 |
| Total Assets | 861.95 | 631.78 | 520.36 |
| Total Borrowings | 325.10 | 87.21 | 69.64 |
| Equity Share Capital | 8.89 | 8.89 | 8.89 |
How to apply for Sahajanand Medical Technologies Limited IPO
There are two simple processes through which any new investors can start their trading journey. One is through UPI, and the other is with the help of a Demat account. The processes are discussed below:
UPI
- Step 1: Open your bank account and link a UPI ID with it
- Step 2: Once your Demat account is all set, link your UPI ID with it
- Step 3: Subscribe to Sahajanand Medical Technologies Limited IPO and accept the payment request on your UPI ID
Demat Account
- Are you a New investor? Open a DEMAT Account for free with Angel One and begin the trading process.
Sahajanand Medical Technologies Limited IPO Noteworthy Highlights:
- Company is Market leading position in interventional cardiology in India, leveraging on industry growth drivers.
- Company's interventional cardiology suite of products, Supraflex, against that of a global leading stent manufacturer demonstrated that Supraflex’s clinical performance is at par on safety factors and numerically superior to others.
- In Fiscals 2019, 2020 and 2021, our revenue from operations was ₹3,261.15 million, ₹4,799.09 million and ₹5,885.21 million, respectively. Our revenue from operations has grown at a CAGR of 21.74% from Fiscal 2019 to Fiscal 2021.
The Brand’s Pros & Cons:
| Pros | Cons |
|---|---|
| The firm competes in a market with high entry barriers, which means there is less competition, and they provide cutting-edge items. | The company's market is heavily regulated, which may make obtaining the necessary approvals for various items more difficult. |
| In India, Sahajanand Med Tech is the market leader in interventional cardiology, with a market share of 31% in FY21. | There may be instances when the firm is unable to carry out its business strategies, which will impede its growth. |
| In addition to direct operations in ten countries, the corporation has distributors in 59 more. | Foreign currency rate changes will have a significant impact on the company's operations. |
Competitive Analysis: Market Peers
| Particulars (In USD Mn) | Medtronic | Boston Scientific | Abbott | Edwards Life Science |
|---|---|---|---|---|
| Revenue | 30,117 | 9,913 | 34,608 | 4,386 |
| EBITDA | 8,236 | 1,723 | 8,618 | 1,431 |
| EBITDA Margin | 27.35% | 17.38% | 24.90% | 32.63% |
| ROE | 7.06 | (0.56) | 13.93 | 18.88 |
| Net Income Margin | 12% | (0.83%) | 12.86% | 18.77% |
| Debt to Equity | 53.29 | 62.73 | 60.67 | 15.19 |
Sahajanand Medical Technologies Limited IPO FAQs
What is Sahajanand Medical Technologies Limited's Initial Public Offering?
When will allotments for the Sahajanand Medical Technologies Limited IPO become available?
What will the IPO lot size for Sahajanand Medical Technologies Limited be?
When will Sahajanand Medical Technologies Limited IPO be available to buy?
What is Sahajanand Medical Technologies Limited’s smallest lot size available to retail investors?
Which exchanges will Sahajanand Medical Technologies Limited list on?
What is the IPO size of Sahajanand Medical Technologies Limited?
How to check the allotment status of Sahajanand Medical Technologies Limited IPO on the AngelOne App?
- Step 1: Login & Look for Investment Opportunities via Angelone App.
- Step 2: Choose IPOs & FPOs.
- Step 3: Click Order Book.
How will I get my Sahajanand Medical Technologies Limited stock?
Can I use one PAN to submit multiple applications for the public issue of Sahajanand Medical Technologies Limited?
Is it necessary to give immediate approval to a UPI mandate request?
Who owns Sahajanand Medical Technologies Limited?
What are the expected listing gains for the Sahajanand Medical Technologies Limited IPO?
- Market movement on the day of the listing.
- Sahajanand Medical Technologies Limited stock market supply and demand from investors and dealers.
- The interest of HNI investors in particular.
Enjoy Zero Brokerage on
Stock Investments
Enjoy Lifetime Free Delivery Trade
Download the app now
Or Scan below QR Code
to download App
